论文部分内容阅读
Beta-adrenergic receptor antagonists （β-blockers） havebeen well established for use in portal hypertensionfor more than three decades. Different Non-selectiveβ-blockers like propranolol, nadolol, timolol, atenolol,metoprolol and carvedilol have been in cl